• Explore /
  • Poster
  • / Outcomes in patients with relapsed/refractory Hodgkin lymphoma (RR-HL) with progression after autologous stem cell transplantation in the current era of novel therapeutics.

Outcomes in patients with relapsed/refractory Hodgkin lymphoma (RR-HL) with progression after autologous stem cell transplantation in the current era of novel therapeutics.

Abstract Poster

Authors

null

Steven Michael Bair

Hospital of the University of Pennsylvania, Philadelphia, PA

Steven Michael Bair , Lauren E. Strelec , Sunita Nasta , Anthony R. Mato , Daniel Jeffrey Landsburg , Edward Allen Stadtmauer , Alison W. Loren , Stephen J. Schuster , Jakub Svoboda

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics

Track

Developmental Therapeutics and Translational Research

Sub Track

Immunoconjugates

Citation

J Clin Oncol 34, 2016 (suppl; abstr 2543)

DOI

10.1200/JCO.2016.34.15_suppl.2543

Abstract #

2543

Poster Bd #

243

Abstract Disclosures

Similar Posters

First Author: Paul David Harker-Murray

First Author: Christopher Parker

First Author: Jagoda Jasielec

First Author: Stefanie Zschaebitz